Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedMajor content and status update: add Adenoid cystic carcinoma and government-operating notice, update to v3.2.0; remove Adrenal cortex carcinoma and v3.1.0.SummaryDifference3%

- Check40 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a new citation/article reference about circulating tumour DNA and salivary duct carcinoma (CABO-ASAP trial). No deletions observed.SummaryDifference2%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has updated its facility name and location details while adding new resources related to various types of cancer, including salivary gland cancer and adrenocortical carcinoma. Additionally, the version has been revised from v2.16.12 to v3.0.0.SummaryDifference2%

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.